AIDS-related lymphomas in Nigeria

Brazilian Journal of Infectious Diseases

Volumn 13, Issue 5, 2009, Pages 359-361

  Bolarinwa, R A ^a   Ndakotsu, M A ^a   Oyekunle, A A ^a   Salawu, L ^a   Akinola, N O ^a   Durosinmi, M A ^a  

^a OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

Author keywords

HIV AIDS; Lymphoma; Nigerians

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BURKITT LYMPHOMA; CANCER STAGING; CARCINOGENESIS; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; DATA ANALYSIS; DISEASE COURSE; EPIDEMIC; FEMALE; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HODGKIN DISEASE; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFERENTIAL STATISTICS; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; NIGERIA; NONHODGKIN LYMPHOMA; PATIENT COUNSELING; PREVALENCE; RETROSPECTIVE STUDY; SCREENING; STATISTICAL ANALYSIS; SURVIVAL TIME; TEACHING HOSPITAL; UNIVERSITY HOSPITAL; B CELL LYMPHOMA; INCIDENCE; MIDDLE AGED;

ADULT; FEMALE; HUMANS; INCIDENCE; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; NIGERIA; PREVALENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77953694671     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702009000500009     Document Type: Article

References (18)

1. Lerime AM. AIDS -related malignancies: The emerging epidemic J. Natt Cancer Inst. 1993;85:1382-1397.
2. Raphael M. Borisch B, Jaffe ES. Lymphomas associated with infection by HIV. In Tumours of Haematopoietic and lymphoid Tissues, WHO classifications of Tumours IARC press 2001:260-263.
3. Mbulaiteve SM, Biggar RJ, Goedert JJ, Engels EA. Immune deficiency and risk and risk for malignancy among persons with AIDS. J Acquir Immune Defic Synd 2003 Apr 15;32(5):527-533.
4. Gottlieb MS, Schroff R, Schanker HM, et al. Pneumocystic Carini pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency N. Engl J Med. 1981; 305: 1425-1431.
5. Beral V, Peterman T, Berkelman R, Jaffe H. AIDS - associated non-Hodgkins lymphoma. Lancet 1991;337: 805-809.
6. Goedert JJ. The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol. 2000; 27: 390-401.
7. Alexander DD, Mink PJ, Ademi H, et al. The Non-Hodgkin lymphomas: A review of epidemiologic literature. Int. J. Cancer. 2007; 120: 1-39
8. Engels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States Int J. Cancer. 2008 Jul 1;123(1):187-194.
9. Ocheni S, Aken'ova YA. Associated between HIV/AIDS and malignancies in a Nigerian tertiary institution. West Afr. J. Med. 2004 Apr- Jun; 23(2): 151 - 155.
10. Chitsike J, Siziya S. Sero-prevalence of human immunodeficiency virus type I (HIV-1) infusion in childhoods malignancy in Zimbabwe Cent. Afr. J. Med. 1998 Oct; 44 (10) 242- 245.
11. Otieno NW, Banura C, Mbidde- Katongole E., et al. Therapeutic challenges of AIDS - related Non- Hodgkin's Lymphoma in the United States and East Africa. Journal of Nat. Cancer Inst. Vol 94(10); 2002: 718 - 726.
12. Bani BJ. The haematological features of HIV infection. Br. J. Haematol. 1997;99:1-8.
13. Akanmu AS AIDS-associated malignancies Afr. J. Med. Med. Sci. 2006 Dec; 35 Suppl: 57- 70.
14. 2005 National HIV/Syphilis sero-prevalence sentinel survey among pregnant women attending antenatal clinics. Federal Ministry of Health Department of Public Health, National AIDS/STDs Control Programme, Technical Report April 2006.
15. Lazzi S, Ferrari F, Nyongo A, et al. HIV - associated malignant lymphomas in Kenya (Equatorial Africa). Hum. Pathol. 1999 Oct: 30(10): 1296 - 1370.
16. Rukujei AD. Epidemiology of HIV/AIDS in Nigeria. Nig. J. Med. 1998; 7:8-10.
17. Durosinmi MA. Cancer: the burden, the control. Inaugural lecture series 213. Obafemi Awolowo University, Nigeria. Obafemi Awolowo University Press Ltd, 2007.
18. Durosinmi MA, Adediran I. Management of cancer under structural adjustment programme (SAP): Experience in Ile-Ife Nigeria. NMJ 1993; 25: 92-96.